Background
Materials and methods
Data sources and preprocessing
Calculation of gene expression differences
Survival analyses
Protein-protein interaction network
Collection of samples
characteristic | Number (N=40) |
---|---|
Age | |
<50 >50 | 17 23 |
Gender | |
Male Female | 22 18 |
Stage | |
I II III IV | 4 17 11 8 |
TNM.N | |
N0 N1 N2 N3 | 7 16 10 7 |
Tumor size | |
<5 cm >5 cm | 16 24 |
Epstein-Barr | |
EBV+ EBV- | 14 26 |
RNA extraction, cDNA synthesis, and RT-qPCR
Statistics and software
Results
Expression changes of many genes related to immune response and cell cycle under the influence of EBV
Exploring the intersection of EBV-influenced genes and GC pathogenesis
The relationship between genes affected by EBV and the mortality rate of patients
Gene names | Univariate | ||
---|---|---|---|
HR | P value | 95% CI | |
NT5DC2 expression (High vs. Low) | 1.32 | 0.03 | 1.01– 1.71 |
KDELC1 expression (High vs. Low) | 1.41 | 0.01 | 1.12– 1.86 |
LRFN1 expression (High vs. Low) | 1.44 | 0.001 | 1.16– 1.95 |
HRNR expression (High vs. Low) | 1.28 | 0.01 | 1.08– 1.69 |
TET1 expression (High vs. Low) | 1.3 | 0.01 | 1.09– 1.69 |
ABCB5 expression (High vs. Low) | 1.32 | 0.002 | 1.09– 1.62 |
ACSL5 expression (High vs. Low) | 0.73 | 0.03 | 0.55– 0.97 |
CAPN8 expression (High vs. Low) | 0.76 | 0.02 | 0.54– 0.96 |
GBP3 expression (High vs. Low) | 0.72 | 0.008 | 0.51– 0.92 |
TRIM36 expression (High vs. Low) | 0.67 | 0.007 | 0.49– 0.91 |
DDX60 expression (High vs. Low) | 0.71 | 0.03 | 0.59– 0.96 |